Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so that they are able to make decisions about their treatment and care. Intended to go beyond “Myeloma 101” they help patients answer key questions: What should myeloma patients do at relapse? Or when they become refractory to treatments? Learn from top myeloma experts about relapsed and high-risk disease and what you can do to stay one step ahead for your best outcomes. This is a great opportunity to ask your questions and meet others in the myeloma community.
Topics will include:
- How Myeloma Genomics Evolve During Treatment
- Chromosomal Translocations and Deletions
- Understanding Minimal Residual Disease (MRD)
- Transplant Issues of Standard and High-Risk Disease
- Monoclonal Antibodies and Immunotherapy
- Emerging Treatment Options Including Vaccines and CAR-T
- Understanding and Choosing Clinical Trials
Date: September 30, 2017
Time: Registration begins at 8:30 am. Session runs from 9:30 am – 3:30 pm.
Site: Rockefeller Auditorium at Memorial Sloan Kettering Cancer Center 430 East 67th Street New York, NY 10065
Cost: Registration is $25 per person. (Please contact firstname.lastname@example.org if you require additional financial assistance)
- Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center
- Guenther Koehne, MD, PhD, Memorial Sloan Kettering Cancer Center
- Ola Landgren, MD, PhD, Memorial Sloan Kettering Cancer Center
- Suzanne Lentzsch, MD, PhD, Columbus University Medical Center
- Ruben Niesvisky, MD, Weill Cornell Medical College
Looking forward to seeing you in New York!
Thanks to our sponsors: